In the three years taken into consideration for this year’s awards, Medtecs’ share price grew at a CAGR of 174.4%; its earnings surged by a CAGR of 430.3% and it delivered a weighted ROE of 52.09 times. In its earnings commentary for the FY2020 ended last December, Medtecs notes that the pandemic has shown little signs of abating this year. This means PPE and healthcare products will continue to be in high demand. Citing unnamed studies, the company notes that the global PPE market is seen to grow at a CAGR of between 6% to 12% between 2020 and 2025.

